Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Behandeling met emicizumab bij ernstige hemofilie alleen in basispakket na prijsdaling
feb 2020 | Benigne hematologie